CRISPR and CAS Genes Global Market Report 2022: Technological Advancements in CRISPR System Fueling Growth - ResearchAndMarkets.com

Based on product & service, the market is bifurcated product and service, In 2021, the product segment accounted for the highest revenue share owing to increased investments in gene editing-based R&D and the emergence of novel applications. However, the availability of improved individual products to achieve numerous goals, such as precise genome cleavage, genome engineering, reduced off-target cutting, and simple gene knockouts is alos driving the market growth.

By Application

On the basis of application, the market is bifurcated into agricultural and biomedical. In 2021, the biomedical applications segment accounted for the highest revenue share owing to the increased use of CRISPR gene-editing techniques in a variety of biological fields, increased effectiveness and specificity of this technique by the use of nano-carriers, improved delivery methods, and extensive biomedical research.

By End user

Based on end user, the market is segregated into academics & government research institutes, pharmaceutical & biotechnology companies, and contract research organizations (CROs). In 2021, the biotechnology and pharmaceutical companies segment accounted for the highest revenue share due to the rising use of CRISPR-CAS9 to create better biological models for human diseases in less time and further accelerate the identification & validation of new therapeutic targets, and increasing significant clinical pipeline based on CRISPR gene-editing technology.

Regional Markets

In 2021, North America region accounted for the highest revenue in the CRISPR and CAS genes market and is expected to maintain its dominance during the forecast period. This is attributed to the region's expanding biopharmaceutical R&D, and the active involvement of numerous pharmaceutical companies in the creation of novel therapeutics through the use of genome editing tools.

Segmentation: CRISPR and CAS Genes Market Report 2021-2029

Product & Service (Revenue, USD Million)

By Application (Revenue, USD Million)

By End user (Revenue, USD Million)

By Region (Revenue, USD Million)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Key Topics Covered:

1. Research Methodology

2. Introduction: CRISPR and CAS Genes

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: CRISPR and CAS Genes Market

7. Market Analysis by Product & Service

8. Market Analysis by Application

9. Market Analysis by End User

10. Regional Market Analysis

11. North America CRISPR and CAS Genes Market

12. Europe CRISPR and CAS Genes Market

13. Asia Pacific CRISPR and CAS Genes Market

14. Latin America CRISPR and CAS Genes Market

15. MEA CRISPR and CAS Genes Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion & Recommendations

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/lndel8

View source version on businesswire.com:https://www.businesswire.com/news/home/20221111005254/en/

    CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

             For GMT Office Hours Call +353-1-416-8900

KEYWORD:
    

INDUSTRY KEYWORD: HEALTH GENETICS
    

SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 11/11/2022 07:02 AM/DISC: 11/11/2022 07:02 AM

http://www.businesswire.com/news/home/20221111005254/en